NICK GREEN
CEO/PRESIDENT
AVID BIOSERVICES
WHY: Spearheaded pivot from failed clinical developer of cancer drugs to being a full-time drug contract manufacturer, more than tripling size of firm since joining in 2020.
IN THE NEWS: Avid last year completed two expansions within the company’s facilities in Tustin, and now has approximately 213K SF spanning two campuses.
NOTABLE: Ranked as the third-largest local drugmaker on this year’s Business Journal list.
QUOTABLE: “We’ve certainly seen a turnaround in people’s focus on what’s manufactured here. We’ve seen more business than we would have. COVID has certainly change people’s mind about the supply chain and supply chain security.”
